These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2636870)

  • 1. Resolution of lymphosarcoma associated blindness in a dog following chemotherapy.
    Butterworth SJ
    Vet Rec; 1989 Sep; 125(11):305. PubMed ID: 2636870
    [No Abstract]   [Full Text] [Related]  

  • 2. [Possibility of the comparative evaluation of chemotherapy effectiveness in hemoblastoses in man and dogs].
    Kliuchanskaia NV; Iliukhin AV
    Vestn Akad Med Nauk SSSR; 1986; (5):68-70. PubMed ID: 3755270
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinico-morphological analysis of chemotherapy effectiveness in spontaneous hemoblastoses in dogs].
    Iliukhin AV; Ponomar'kov VI; Kliuchanskaia NV
    Vopr Onkol; 1985; 31(3):88-91. PubMed ID: 3857785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of some prognostic factors for advanced multicentric lymphosarcoma in the dog: 147 cases (1978-1981).
    MacEwen EG; Hayes AA; Matus RE; Kurzman I
    J Am Vet Med Assoc; 1987 Mar; 190(5):564-8. PubMed ID: 3558097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and toxicity of doxorubicin/cyclophosphamide maintenance therapy in dogs with multicentric lymphosarcoma.
    Price GS; Page RL; Fischer BM; Levine JF; Gerig TM
    J Vet Intern Med; 1991; 5(5):259-62. PubMed ID: 1748977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of the successful use of nitrosomethylurea in lymphosarcoma complicated by prolonged massive chylothorax].
    Korman DB; Snimshchikov VA
    Vopr Onkol; 1992; 38(7):859-61. PubMed ID: 1300793
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic variables in canine multicentric lymphosarcoma.
    Dobson JM; Blackwood LB; McInnes EF; Bostock DE; Nicholls P; Hoather TM; Tom BD
    J Small Anim Pract; 2001 Aug; 42(8):377-84. PubMed ID: 11518416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy for Australian cats with lymphosarcoma.
    Malik R; Gabor LJ; Foster SF; McCorkell BE; Canfield PJ
    Aust Vet J; 2001 Dec; 79(12):808-17. PubMed ID: 11837901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a multi-agent chemotherapy protocol combining lomustine, procarbazine and prednisolone (LPP) for the treatment of relapsed canine non-Hodgkin high-grade lymphomas.
    Tanis JB; Mason SL; Maddox TW; Blackwood L; Killick DR; Amores-Fuster I; Harper A; Finotello R
    Vet Comp Oncol; 2018 Sep; 16(3):361-369. PubMed ID: 29380942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of factors associated with second remission in dogs with lymphoma undergoing retreatment with a cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy protocol: 95 cases (2000-2007).
    Flory AB; Rassnick KM; Erb HN; Garrett LD; Northrup NC; Selting KA; Phillips BS; Locke JE; Chretin JD
    J Am Vet Med Assoc; 2011 Feb; 238(4):501-6. PubMed ID: 21320021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of non-Hodgkin's lymphoma with mitoxantrone-containing regimens.
    Sonneveld P
    Semin Oncol; 1995 Feb; 22(1 Suppl 1):29-31. PubMed ID: 7863349
    [No Abstract]   [Full Text] [Related]  

  • 12. [Results of combined chemotherapy of lymphosarcoma with cyclophosphamide, vincristine and prednisolone].
    Abdyldaev RA; Kruglova GV
    Vopr Onkol; 1983; 29(4):83-5. PubMed ID: 6687966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus-related lymphoma: prognostic factors predictive of survival.
    Taillan B; Garnier G; Schneider S; Pesce A; Fuzibet JG; Dujardin P
    Cancer; 1993 May; 71(9):2881-2. PubMed ID: 7682156
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclic combination chemotherapy of canine lymphosarcoma.
    MacEwen EG; Brown NO; Patnaik AK; Hayes AA; Passe S
    J Am Vet Med Assoc; 1981 Jun; 178(11):1178-81. PubMed ID: 6895078
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
    Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA
    Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primary non-Hodgkin lymphoma of the sternum].
    Kabiri el H; Kabiri M; Doghmi K
    Arch Bronconeumol; 2009 May; 45(5):259-60. PubMed ID: 19376627
    [No Abstract]   [Full Text] [Related]  

  • 17. Retrospective analysis for treatment of naïve canine multicentric lymphoma with a 15-week, maintenance-free CHOP protocol.
    Curran K; Thamm DH
    Vet Comp Oncol; 2016 Aug; 14 Suppl 1():147-55. PubMed ID: 26279153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The combined chemoradiotherapy of lymphosarcomas].
    Kruglova GV; Finogenova IA
    Ter Arkh; 1995; 67(10):60-3. PubMed ID: 8779110
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical treatment of MST-16 (Sobuzoxane) for malignant lymphoma].
    Nakayama S; Yabe H; Nagai K
    Gan To Kagaku Ryoho; 1991 Sep; 18(12):2179-82. PubMed ID: 1888191
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of combination chemotherapy with cis-dichlorodiammineplatinum on relapsed or therapy-resistant non-Hodgkin's lymphoma].
    Tsukasaki K; Ikeda S; Momita S; Nagai K; Murata K; Tokunaga S; Kohno T; Itoyama T; Toriya K; Kuriyama K
    Rinsho Ketsueki; 1988 May; 29(5):699-704. PubMed ID: 3216496
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.